Clinical Trials Logo
  1. Home
  2. GVHD, Chronic
  3. NCT05401955

Physiotherapy and Therapeutic Exercise Program in Graft-versus-host Disease (GvHD)

GVHD,Acute Clinical Trial

Official title:
Effects of a Physical Therapy and Therapeutic Exercise Program in Graft-versus-host Disease (GVHD)

Clinical Trial Summary

Range of motion, antropometric measurements, quality of life questionnaire and 2 minutes walk test will be implemented as an initial assessment. Physical exercise program will take 2 sessions a week for six months, and several follow-ups: before, during and after treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05401955
Study type Interventional
Source University of Salamanca
Contact
Status Recruiting
Phase N/A
Start date May 1, 2022
Completion date July 30, 2023
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05855707 - Wharton Jelly Mesenchymal Stromal Cells as GVHD Prophylaxis Phase 1
Active, not recruiting NCT04522843 - Analysis of Intestinal Defensin Expression in Acute GVHD
Recruiting NCT05718791 - CXCL9 and EASIX for Prediction of Acute Graft Versus Host Disease
Recruiting NCT05368181 - MAP-guided Preemptive Therapy of aGvHD Phase 2
Withdrawn NCT05443464 - Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD) Phase 1
Not yet recruiting NCT06315309 - Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant Phase 2
Terminated NCT04220632 - A Study of IBI377 in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease Phase 1/Phase 2
Recruiting NCT04284904 - Role of aGVHD Biomarkers on aGVHD Risks
Not yet recruiting NCT06164288 - Safety and Efficacy Study of hAESCs Therapy for aGVHD Phase 1